25 LLC’s HCA Healthcare HCA Stock Holding History

25 LLC’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2	Closed	-$556	–	660
2023 Q1	$556	Buy	+2	New	+$508	﹤0.01%	286

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

25 LLC's HCA Position: Q2 2023 in Review

25 LLC sold out of HCA Healthcare (HCA) in Q2 2023, closing a stake of 2 shares — an estimated $556 sold.

25 LLC first reported a position in HCA in Q1 2023 and held it in 1 quarter. The position peaked at $556 in Q1 2023. 1,013 funds tracked by Wall St. Rank hold HCA as of Q2 2023.

25 LLC reported no remaining HCA Healthcare position as of Q2 2023 after selling out during the quarter.
25 LLC sold 2 HCA Healthcare shares in Q2 2023, an estimated $556.
25 LLC first reported a position in HCA Healthcare in Q1 2023 and held it in 1 quarter.
25 LLC's HCA Healthcare position peaked at $556 in Q1 2023.
1,013 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2023.

Based on 25 LLC's 13F filing for Q2 2023, filed 19 Jul 2023.